Table 1 Patient demographics and clinical details
Demographic / clinical data | Value |
|---|---|
Number of patients recruited | 13 |
Female [%] | 8 [53%] |
Age: median [IQR, range] years | 65 [61–73, 44–85] |
Time since RA diagnosis: median [IQR] years | 10 [3–13] |
RhF and/or ACPA positive: n [%] | 9 [69%] |
Current use of methotrexate: n [%] | 11 [85%] |
Current use of hydroxychloroquine: n [%] | 1 [8%] |
Current use of sulfasalazine: n [%] | 2 [15%] |
Current use of biologics: n [%] | 2 [15%] |
DAS28: median [IQR] | 1.56 [1.35–2.44] |